Cargando…
Molecular and cellular pharmacology /
Molecular and Cellular Pharmacology.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Greenwich, Conn. :
JAI Press,
�1997.
|
| Colección: | Principles of medical biology ;
v. 8A-8C. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo Texto completo Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn166434539 | ||
| 003 | OCoLC | ||
| 005 | 20231117015045.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070830s1997 ctua ob 001 0 eng d | ||
| 040 | |a OPELS |b eng |e pn |c OPELS |d OPELS |d OCLCQ |d EBLCP |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCF |d OCLCQ |d CHVBK |d OCL |d UA@ |d YDXCP |d TULIB |d OCLCQ |d DEBSZ |d UAB |d OCLCQ |d CASUM |d OCLCO |d OCLCA |d D6H |d OCLCO |d OL$ |d OCLCO |d WURST |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 019 | |a 779916877 | ||
| 020 | |a 9781559388139 | ||
| 020 | |a 1559388137 | ||
| 035 | |a (OCoLC)166434539 |z (OCoLC)779916877 | ||
| 050 | 4 | |a RM301.41 |b .M65 1997eb | |
| 060 | 4 | |a 1998 A-311 | |
| 060 | 4 | |a QV 38 |b M7179 1997 | |
| 082 | 0 | 4 | |a 615/.7 |2 22 |
| 245 | 0 | 0 | |a Molecular and cellular pharmacology / |c edited by E. Edward Bittar, Neville Bittar. |
| 260 | |a Greenwich, Conn. : |b JAI Press, |c �1997. | ||
| 300 | |a 1 online resource (3 volumes (xxviii, 1111 pages)) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Principles of medical biology ; |v v. 8A-8C | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a 1. Receptors: Topology, organization, and function -- 2. Adrenergic and muscarinic cholinergic receptors -- 3. 5-Hydroxytryptamine receptors -- 4. Dopamine receptors -- 5. GABAA receptors in the central nervous system -- 6. Excitatory amino acid receptors -- 7. Substance P -- 8. Pharmacology and molecular biology of opioid receptors -- 9. Inositol 1,4,5-trisphosphate receptors -- 10. The LDL receptor -- 11. Angiotensin II peptide hormone receptors: Structure/function correlates -- 12. Melanocortin receptors -- 13. Pharmacology in the critically III -- 14. Principles of drug metabolism -- 15. Adrenergic drugs -- 16. Cholinergic Agents -- 17. Rational methods for site-directed drug design -- 18. The advantages of liposome-based gene therapy: A comparison of viral versus liposome-based gene delivery -- 19. The kallikrein-kinin-kininogen system -- 20. Cellular responses to eicosanoids: Molecular biology of eicosanoid receptors -- 21. Nitric oxide as a bioregulator -- 22. Medicinal Chemistry of steroids -- 23. The influence of anabolic steroids on muscular strength -- 24. Genomic pharmacology: From receptor internalization to nuclear translocation of third messengers -- 25. Cardiac glycosides -- 26. Antiarrhythmic drugs -- 27. The tissue specificity of calcium antagonists -- 28. Mode of action of angiotensin converting enzyme inhibitors -- 29. Mode of action of lipid-lowering drugs -- 30. The physiologic basis of diuretic drug action and synergism -- 31. Insulin and hypolycemic drugs -- 32. Hypnotics and anti-anxiety agents -- 33. Accurate diagnosis and drug selection in patients with chronic pain -- 34. Leukotrienes -- 35. Anti-inflammatory drugs: Mechanisms of action -- 36. Treatment of gout and hyperuricemia -- 37. Idiosyncratic drug reactions -- 38. Treatment of convulsive disorders -- 39. General anesthetics -- 40. Cellular mechanisms of anesthesia -- 41. Alcohol and alcoholism -- 42. The mode of action and metabolism of vitamin A -- 43. Vitamin A binding proteins -- 44. Biochemistry of the visual cycle -- 45. Vitamin B12 -- 46. Vitamin C -- 47. The prehormone vitamin D -- 48. Vitamin E -- 49. Vitamin K: Metabolic functions, mechanism of action, and human requirements -- 50. Selenium in nutrition and therapeutics -- 51. The dependence syndrome concept for alcohol and drug abuse -- 52. Opioid tolerance and dependence -- 53. Activation mechanisms of chemical toxicity -- 54. Mechanisms of cell toxicity -- 55. The blood-brain barrier as a protector against neurotoxic agents -- 56. Chelating agents as antidotes of metal poisoning. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Molecular and Cellular Pharmacology. | ||
| 650 | 0 | |a Drug receptors. | |
| 650 | 0 | |a Molecular pharmacology. | |
| 650 | 0 | |a Cells |x Effect of drugs on. | |
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Medicine. | |
| 650 | 0 | |a Chemotherapy. | |
| 650 | 1 | 2 | |a Receptors, Drug |x metabolism |0 (DNLM)D011955Q000378 |
| 650 | 2 | 2 | |a Cells |x drug effects |0 (DNLM)D002477Q000187 |
| 650 | 2 | 2 | |a Drug Therapy |0 (DNLM)D004358 |
| 650 | 2 | 2 | |a Neurotransmitter Agents |x pharmacology |0 (DNLM)D018377Q000494 |
| 650 | 2 | 2 | |a Steroids |x chemistry |0 (DNLM)D013256Q000737 |
| 650 | 2 | 2 | |a Vitamins |x pharmacology |0 (DNLM)D014815Q000494 |
| 650 | 2 | |a Receptors, Drug |0 (DNLM)D011955 | |
| 650 | 2 | |a Medicine |0 (DNLM)D008511 | |
| 650 | 6 | |a R�ecepteurs de m�edicaments. |0 (CaQQLa)201-0010864 | |
| 650 | 6 | |a Pharmacologie mol�eculaire. |0 (CaQQLa)201-0165543 | |
| 650 | 6 | |a Cellules |x Effets des m�edicaments sur. |0 (CaQQLa)201-0005069 | |
| 650 | 6 | |a M�edecine. |0 (CaQQLa)201-0055077 | |
| 650 | 6 | |a Chimioth�erapie. |0 (CaQQLa)201-0034750 | |
| 650 | 7 | |a medicines (material) |2 aat |0 (CStmoGRI)aat300404880 | |
| 650 | 7 | |a medicine (discipline) |2 aat |0 (CStmoGRI)aat300054518 | |
| 650 | 7 | |a Chemotherapy |2 fast |0 (OCoLC)fst00853595 | |
| 650 | 7 | |a Cells |x Effect of drugs on |2 fast |0 (OCoLC)fst00850258 | |
| 650 | 7 | |a Drug receptors |2 fast |0 (OCoLC)fst00898699 | |
| 650 | 7 | |a Medicine |2 fast |0 (OCoLC)fst01014893 | |
| 650 | 7 | |a Molecular pharmacology |2 fast |0 (OCoLC)fst01024822 | |
| 650 | 7 | |a Pharmacy |2 fast |0 (OCoLC)fst01060285 | |
| 653 | 0 | 0 | |a farmacologie |
| 653 | 0 | 0 | |a pharmacology |
| 653 | 0 | 0 | |a medische behandeling |
| 653 | 0 | 0 | |a medical treatment |
| 653 | 0 | 0 | |a geneesmiddelen |
| 653 | 0 | 0 | |a drugs |
| 653 | 1 | 0 | |a Pharmacology |
| 653 | 1 | 0 | |a Farmacologie |
| 700 | 1 | |a Bittar, E. Edward. | |
| 700 | 1 | |a Bittar, Neville. | |
| 776 | 0 | 8 | |i Print version: |t Molecular and cellular pharmacology. |d Greenwich, Conn. : JAI Press, �1997 |z 1559388137 |z 9781559388139 |w (DLC) 97015195 |w (OCoLC)36729048 |
| 830 | 0 | |a Principles of medical biology ; |v v. 8A-8C. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781559388139 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/issue/28519-1997-999919999.7998-648088 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/issue/28519-1997-999919999.7997-647963 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/issue/28519-1997-999919999.7996-647964 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/15692582/8 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/publication?issn=15692582&volume=8 |z Texto completo |